Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Granger

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Circulation|January 5, 2000
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial InvestigatorsB S Crenshaw, C B Granger, Y Birnbaum, et al.
American Heart Journal|February 26, 2000
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trialsS J Brener, S G Ellis, S K Sapp, et al.
The American Journal of Cardiology|December 1, 2001
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-TrialB G Angeja, J H Alexander, R Chin, et al.
Heart (British Cardiac Society)|February 28, 2009
Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary EventsD Brieger, K A A Fox, G Fitzgerald, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Circulation|November 3, 1998
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb InvestigatorsP W Armstrong, Y Fu, W C Chang, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
Circulation|June 3, 1997
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I InvestigatorsS D Berkowitz, C B Granger, K S Pieper, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Circulation|January 5, 2000
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial InvestigatorsB S Crenshaw, C B Granger, Y Birnbaum, et al.
American Heart Journal|February 26, 2000
Predictors of death and reinfarction at 30 days after primary angioplasty: the GUSTO IIb and RAPPORT trialsS J Brener, S G Ellis, S K Sapp, et al.
The American Journal of Cardiology|December 1, 2001
Safety of the weight-adjusted dosing regimen of tenecteplase in the ASSENT-TrialB G Angeja, J H Alexander, R Chin, et al.
Heart (British Cardiac Society)|February 28, 2009
Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary EventsD Brieger, K A A Fox, G Fitzgerald, et al.
Journal of the American College of Cardiology|March 27, 2001
Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromesM C Bahit, E J Topol, R M Califf, et al.
Circulation|November 3, 1998
Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. The GUSTO-IIb InvestigatorsP W Armstrong, Y Fu, W C Chang, et al.
Journal of the American College of Cardiology|December 31, 1997
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesK W Mahaffey, C B Granger, C A Toth, et al.
Circulation|June 3, 1997
Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I InvestigatorsS D Berkowitz, C B Granger, K S Pieper, et al.
Circulation|November 16, 1999
Cardiogenic shock in patients with acute ischemic syndromes with and without ST-segment elevationD R Holmes, P B Berger, J S Hochman, et al.
JAMA|February 12, 1998
Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary ArteriesW R Hathaway, E D Peterson, G S Wagner, et al.
Pageof 14